ARECOR
Live / Registered — Registered (as of 23 Apr 2024)
What this means for you
Registered since 23 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79327240
- Registration number
- 7361956
- Mark type
- Stylized text
- Filed
- 28 Sept 2021
- Published for opposition
- 06 Feb 2024
- Registered
- 23 Apr 2024
- Attorney of record
- Amanda M. Prose
Goods and services
- Class 005 — Pharmaceuticals: Medical preparations, namely, diagnostic preparations for medical purposes, preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infective, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders; Medicinal products, namely, pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infective, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders; Pharmaceuticals, namely, preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infective, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders; Biopharmaceuticals, namely, preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, metabolic, immune-oncology, oncology, anti-infectives, neuroscience, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmology, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, rare diseases, autoimmune, inflammatory, immunology, pain, infectious diseases, renal, reproductive health and childbirth, blood disorders, vaccines, haematological related diseases and disorders
- Class 042 — Scientific and technological services: Medical and pharmacological research services; consultancy in the field of pharmaceutical research and development; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation and development; research and development of vaccines and medicines
Owner
- Arecor Limited, GB
- Arecor Limited, GB
- Arecor Limited, GB
Prosecution history
- 09 Nov 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 22 Oct 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Oct 2024 — FINAL DISPOSITION PROCESSED
- 24 Jul 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 23 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 06 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Feb 2024 — PUBLISHED FOR OPPOSITION
- 05 Feb 2024 — NOTIFICATION PROCESSED BY IB
- 17 Jan 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 17 Jan 2024 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 17 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jan 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE